Your browser doesn't support javascript.
loading
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
Stirling, Elizabeth R; Terabe, Masaki; Wilson, Adam S; Kooshki, Mitra; Yamaleyeva, Liliya M; Alexander-Miller, Martha A; Zhang, Wei; Miller, Lance D; Triozzi, Pierre L; Soto-Pantoja, David R.
Afiliação
  • Stirling ER; Department of Cancer Biology, Wake Forest Univerisity School of Medicine, Winston-Salem, North Carolina, USA.
  • Terabe M; Neuro-Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Wilson AS; Department of Surgery, Wake Forest Univerisity School of Medicine, Winston-Salem, North Carolina, USA.
  • Kooshki M; Department of Hematology & Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Yamaleyeva LM; Department of Radiation Oncology, Wake Forest University School of Medicine, WInston-Salem, North Carolina, USA.
  • Alexander-Miller MA; Department of Surgery, Wake Forest Univerisity School of Medicine, Winston-Salem, North Carolina, USA.
  • Zhang W; Department of Microbiology & Immunology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Miller LD; Department of Cancer Biology, Wake Forest Univerisity School of Medicine, Winston-Salem, North Carolina, USA.
  • Triozzi PL; Atrium Health Wake Forest Baptist Medical Center, Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.
  • Soto-Pantoja DR; Department of Cancer Biology, Wake Forest Univerisity School of Medicine, Winston-Salem, North Carolina, USA.
J Immunother Cancer ; 10(11)2022 11.
Article em En | MEDLINE | ID: mdl-36418073

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Antígeno CD47 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Antígeno CD47 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article